17/09/2023
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
September 2023
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Oct »
17/09/2023
Sep 17, 2023, 17:42 |
Insight
Khalid El Bairi: Happy to share this new paper published by the ASCO Post, in which I discuss my recent trip to Japan for ASCOBT23.
Quoting Khalid El Bairi, Founder of Cancer Biomarkers Working Group, on LinkedIn: ''Happy to share…
Sep 17, 2023, 17:27 |
Blog
Avi Steindel: SparkCures has launched a partnership with the MDS Foundation to revolutionize clinical trial matching for people living with myelodysplastic syndromes (MDS) and related diseases.
Sep 17, 2023, 17:10 |
Blog
Mark Lewis: Quite possibly the best review of functional pancreatic neuroendocrine tumors (and their management) that I've ever read.
Quoting Mark Lewis on X/Twitter: ''Quite possibly the best review of functional pancreatic neuroendocrine tumors…
Sep 17, 2023, 17:03 |
Blog
Vanessa Valdivia: It was really special to mark that moment by having the First Lady join Latino leaders in Atlanta, Georgia to kick off Hispanic Heritage month.
Vanessa Valdivia, Press Secretary to the First Lady and Special Assistant to the President of…
Sep 17, 2023, 16:54 |
Opinion
Andres Gomez: In my view, the most important issue for AML patients worldwide is lack of access to comprehensive testing.
Quoting Andres Gomez, Associate Professor at UANL Monterrey, Mexico, on X/Twitter: "I like the paper…
Sep 17, 2023, 16:42 |
Insight
Felipe Roitberg: A powerful Tool for decision-making process support.
Quoting Felipe Roitberg, Technical Officer (Cancer-NCD) at the World Health Organization, Ukraine, on LinkedIn: “Just…
Sep 17, 2023, 16:34 |
Blog
Dr. Chagaluka and Dr. Chimalizeni and partners had a fruitful meeting. - CANCaRe Africa
Quoting CANCaRe Africa on X/Twitter: "The Collaborative African Network for Clinical Care and Research for…
Sep 17, 2023, 16:13 |
Career
Congratulations to Dr. Michel Sadelain for receiving the 2024 Breakthrough Prize Foundation's Prize in Life Sciences for the development of chimeric antigen receptor T cell immunotherapy. - Memorial Sloan Kettering Cancer Center
1
2
All:
18
Posts:
11 - 20
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube